ADiTx Inc (ADTX): Really up 72% lol

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

ADiTx Inc (ADTX)

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	167
Posts	22620
Boards Moderated	0
Alias Born	11/01/2012

Re: jr525 post# 162

Friday, 07/08/2022 11:35:06 AM

Friday, July 08, 2022 11:35:06 AM

Really up 72% lol

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ADTX News

Form 8-K - Current report • Edgar (US Regulatory) • 06/01/2026 12:30:22 PM
Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders • Business Wire • 06/01/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2026 08:21:24 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2026 09:03:44 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2026 08:31:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:20:52 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2026 08:20:06 PM
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026 • Business Wire • 05/14/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 08:20:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:35:47 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/23/2026 08:30:42 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/22/2026 04:15:21 AM
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients • Business Wire • 04/20/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 12:00:13 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/11/2026 01:49:19 AM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/07/2026 08:02:58 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2026 08:37:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:13:36 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:35:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 12:00:37 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/27/2026 09:02:12 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/24/2026 09:21:36 PM
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer • Business Wire • 03/19/2026 12:15:00 PM
Aditxt Acquires Ignite Proteomics to Expand Precision Oncology Capabilities • IH Market News • 03/13/2026 03:36:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 12:35:24 PM

More ADTX News

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow